CLOV
Clover Health Investments Corp
4.80$
+4.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 88.4% | 69.4% | 85.7% | 108.0% | 107.0% | 111.2% | 102.1% | 102.3% | 98.6% | 101.4% | 98.0% | 99.4% | 85.3% | 76.3% | 77.0% | 87.8% | 76.4% | 69.7% | 75.5% | 72.1% | 76.4% | 79.1% | 85.3% | 84.8% | 78.7% | 79.4% | 81.4% | |
| 100.0% | 100.0% | 100.0% | – | 11.6% | 30.6% | 14.3% | -8.0% | -7.0% | -11.2% | -2.1% | -2.3% | 1.4% | -1.4% | 2.0% | 0.6% | 14.7% | 23.7% | 23.0% | 12.2% | 23.6% | 30.3% | 24.5% | 27.9% | 23.6% | 20.9% | 14.7% | 15.2% | 21.3% | 20.6% | 18.6% | |
| 19.5% | 19.5% | 16.6% | – | 30.2% | 23.6% | 27.5% | 33.1% | 52.2% | 26.1% | 27.9% | 26.4% | 14.5% | 13.9% | 13.8% | 13.8% | 39.3% | 32.5% | 33.2% | 21.5% | 29.9% | 28.0% | 27.3% | 34.1% | 23.7% | 23.0% | 19.6% | 28.8% | 17.6% | 16.7% | 19.9% | |
| 195.5% | 195.5% | 137.3% | – | 27.7% | 17.2% | 27.1% | 32.7% | 52.4% | 32.9% | 32.8% | 41.0% | 11.5% | 10.7% | 10.6% | 12.5% | 39.4% | 32.7% | 33.9% | 25.1% | 30.1% | 28.3% | 27.2% | 34.2% | 23.8% | 23.1% | 19.6% | 25.3% | 17.6% | 16.8% | 19.3% | |
| -37.6% | -37.6% | -26.1% | – | -16.1% | 13.5% | -12.8% | -40.7% | -59.4% | -44.1% | -34.9% | -43.2% | -10.0% | -12.1% | -8.6% | -11.9% | -24.8% | -9.0% | -11.0% | -12.9% | -6.5% | 2.0% | -2.7% | -6.4% | -0.3% | -2.2% | -4.9% | -10.1% | 3.6% | 3.8% | -0.7% | |
| – | – | – | – | 8.2% | 7.7% | 8.1% | 10.0% | 7.4% | 0.3% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -99.0% | -99.0% | -43.6% | – | -17.0% | 3.1% | 7.5% | -76.0% | -24.2% | -77.0% | -8.1% | -43.3% | -8.6% | -12.3% | -8.8% | -9.4% | -24.8% | -9.0% | -11.0% | -13.8% | -6.7% | 2.0% | -2.7% | -6.4% | -0.3% | -2.2% | -4.9% | -10.1% | 3.6% | 3.8% | -0.7% | |
| -61.4% | -61.4% | -17.6% | – | 8.2% | 7.7% | 8.1% | 10.0% | 7.4% | 0.3% | 0.1% | 0.1% | -1.4% | 0.1% | 0.1% | -2.5% | -22.5% | 0.0% | 0.2% | -12.9% | -0.2% | -12.7% | – | – | – | – | – | – | – | – | – | |
| -99.0% | -99.0% | -43.6% | – | -17.0% | 3.1% | 7.5% | -76.0% | -24.2% | -77.0% | -8.1% | -43.3% | -8.6% | -12.3% | -8.8% | -9.4% | -22.5% | -9.0% | -13.6% | -13.8% | -5.5% | 2.1% | -2.8% | -6.6% | -0.3% | -2.2% | -4.9% | -10.1% | 3.6% | 3.8% | -0.7% | |
| -61.4% | -61.4% | -17.6% | – | -8.8% | 11.0% | 15.7% | -66.0% | -16.7% | -76.7% | -8.0% | -43.0% | -8.5% | -12.2% | -8.7% | -9.4% | -24.1% | -8.7% | -10.8% | -13.7% | -6.4% | 2.1% | -2.7% | -6.3% | -0.2% | -2.1% | -4.8% | -10.0% | 3.7% | 3.8% | -0.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.